All Posts

COCO had a GLB on 3/24 and the volume shows spikes of buying since February. MarketSmith says COCO has a Comp Rating=94 and AccDis Rating =A+.  RS=99.  I like the fact that COCO is  now 3x its lowest price the past year. And 2023 earnings are projected to rise +371%.  Here are the daily, monthly and weekly charts. I have a small position in COCO. COCO is right up against its 15.2 upper Bollinger band and may be extended now. It finds support at its 8 EMA, the upper dotted line.

The monthly chart shows COCO to have an IPO break-out pattern.

This weekly chart shows COCO riding its 4 wk avg, the red dotted line.

$LLY may soon receive approval for their obesity drug, which may prove to be a blockbuster drug. It appears that the stock is rising in anticipation of results from a second Phase 3 trial, expected this month. This could be big if LLY can break above its green line ATH peak at $375.25. I have a very small position and will add to it if we get a GLB (green line break-out). Thanks to my stock buddy, Judy, for telling me about LLY many months ago.

The green line ATH is at 194.45 set in 2020.  GLD may eventually break out of its 3 year consolidation. There may be a lot of sellers around the old peak. I will therefore wait for it to break out to an ATH on above average volume.